Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Balixafortide (a CXCR4 antagonist) plus eribulin in HER2 negative metastatic breast cancer: Dose-response analysis of efficacy from phase I single-arm trialKaufman, Peter A. ; Pernas Simon, Sonia ; Martin, Miguel ; Gil-Martin, Marta ; Gomez Pardo, Patricia ; Lopez-Tarruella, Sara ; Manso, Luis ; Ciruelos, Eva ; Perez-Fidalgo, Jose Alejandro ; Hernando, Cristina ; Ademuyiwa, Foluso Olabisi ; Weilbaecher, Katherine N. ; Mayer, Ingrid A. ; Pluard, Timothy J. ; Martinez Garcia, Maria ; Vahdat, Linda T. ; Ringeisen, Francois Philippe ; Bobirca, Alexandra ; Cortes, JavierJournal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15209-e15209 [Periódico revisado por pares]Texto completo disponível |
|
2 |
Material Type: Artigo
|
Balixafortide (a CXCR4 antagonist) + eribulin in HER2-negative metastatic breast cancer (MBC): Survival outcomes of the phase I trialKaufman, Peter A. ; Pernas Simon, Sonia ; Martin, Miguel ; Gil-Martin, Marta ; Gomez Pardo, Patricia ; Lopez-Tarruella, Sara ; Manso, Luis ; Ciruelos, Eva ; Perez-Fidalgo, Jose Alejandro ; Hernando, Cristina ; Ademuyiwa, Foluso Olabisi ; Weilbaecher, Katherine N. ; Mayer, Ingrid A. ; Pluard, Timothy J. ; Martinez Garcia, Maria ; Vahdat, Linda T. ; Barker, Debra ; Romagnoli, Barbara ; Cortes, JavierJournal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.2606-2606 [Periódico revisado por pares]Texto completo disponível |
|
3 |
Material Type: Artigo
|
Dose escalation of POL6326 in combination with eribulin in HER2-negative relapsed metastatic breast cancer (mBCa) patients (pts)Pernas Simon, Sonia ; Cortes, Javier ; Ademuyiwa, Foluso Olabisi ; Lopez-Tarruella, Sara ; Manso, Luis ; Kaufman, Peter ; Hooftman, Leon W. ; Romagnoli, Barbara ; Perez-Fidalgo, Jose Alejandro ; Pluard, Timothy J. ; Weilbaecher, Katherine N. ; Gomez Pardo, PatriciaJournal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.2548-2548 [Periódico revisado por pares]Texto completo disponível |
|
4 |
Material Type: Artigo
|
Phase I study of the combination of balixafortide (CXCR4 inhibitor) and eribulin in HER2-negative metastatic breast cancer (MBC) patients (pts)Gil-Martin, Marta ; Gomez Pardo, Patricia ; Lopez-Tarruella, Sara ; Manso, Luis ; Perez-Fidalgo, Jose Alejandro ; Ademuyiwa, Foluso Olabisi ; Mayer, Ingrid A. ; Pluard, Timothy J. ; Martinez Garcia, Maria ; Kaufman, Peter A. ; Vahdat, Linda T. ; Hooftman, Leon W. ; Romagnoli, Barbara ; Hernando, Cristina ; Weilbaecher, Katherine N. ; Ciruelos, Eva M. ; Martin, Miguel ; Pernas Simon, Sonia ; Cortes, JavierJournal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2555-2555 [Periódico revisado por pares]Texto completo disponível |